The University of Texas MD Anderson Cancer Center
ORCID: 0000-0003-2623-4713Also affiliated with Lexicon Pharmaceuticals (United States)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: “Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer”.
Frederick S. Robinson, Rosalba Minelli, Hideo Tomihara, Bahar Salimian Rizi, Johnathon L. Rose +30 more